NAVB Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

As of 07/23/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/1992
Outstanding shares:  29,025,412
Average volume:  115,099
Market cap:   $53,406,758
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    63937X202
ISIN:        US63937X2027
Sedol:      BJHDL45
Valuation   (See tab for details)
PE ratio:   -4.37
PB ratio:   3.64
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy